Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Chemotherapy vs Standard Therapy in Metastatic Breast Cancer
NCT00003032Phase 3Completed
- Sponsor
- Canadian Cancer Trials Group
- Start
- Apr 1997
- Primary completion
- Apr 2001
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of cyclophosphamide, mitoxantrone, carboplatin in breast cancer, sponsored by Canadian Cancer Trials Group. Started Apr 1997; status: completed.
02
Drugs
cyclophosphamidemitoxantronecarboplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003032.